How Can a Ketogenic Diet Improve Motor Function?

A ketogenic diet (KD) is a normocaloric diet composed by high fat (80–90%), low carbohydrate, and low protein consumption that induces fasting-like effects. KD increases ketone body (KBs) production and its concentration in the blood, providing the brain an alternative energy supply that enhances oxidative mitochondrial metabolism. In addition to its profound impact on neuro-metabolism and bioenergetics, the neuroprotective effect of specific polyunsaturated fatty acids and KBs involves pleiotropic mechanisms, such as the modulation of neuronal membrane excitability, inflammation, or reactive oxygen species production. KD is a therapy that has been used for almost a century to treat medically intractable epilepsy and has been increasingly explored in a number of neurological diseases. Motor function has also been shown to be improved by KD and/or medium-chain triglyceride diets in rodent models of Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, and spinal cord injury. These studies have proposed that KD may induce a modification in synaptic morphology and function, involving ionic channels, glutamatergic transmission, or synaptic vesicular cycling machinery. However, little is understood about the molecular mechanisms underlying the impact of KD on motor function and the perspectives of its use to acquire the neuromuscular effects. The aim of this review is to explore the conditions through which KD might improve motor function. First, we will describe the main consequences of KD exposure in tissues involved in motor function. Second, we will report and discuss the relevance of KD in pre-clinical and clinical trials in the major diseases presenting motor dysfunction.

[1]  H. Buckle,et al.  [Angelman syndrome]. , 2019, Nursing RSA = Verpleging RSA.

[2]  S. Masino,et al.  Ketone-Based Metabolic Therapy: Is Increased NAD+ a Primary Mechanism? , 2017, Front. Mol. Neurosci..

[3]  Jia Liu,et al.  Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications , 2017, Front. Immunol..

[4]  L. Zuo,et al.  Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications , 2017, Oxidative medicine and cellular longevity.

[5]  R. Swerdlow,et al.  Neuroketotherapeutics: A modern review of a century-old therapy , 2017, Neurochemistry International.

[6]  V. Meininger,et al.  A decrease in blood cholesterol after gastrostomy could impact survival in ALS , 2017, European Journal of Clinical Nutrition.

[7]  M. Mattson,et al.  Effects of a dietary ketone ester on hippocampal glycolytic and tricarboxylic acid cycle intermediates and amino acids in a 3xTgAD mouse model of Alzheimer's disease , 2017, Journal of neurochemistry.

[8]  C. Rae,et al.  β-Hydroxybutyrate Boosts Mitochondrial and Neuronal Metabolism but is not Preferred Over Glucose Under Activated Conditions , 2017, Neurochemical Research.

[9]  P. Rada,et al.  A ketogenic diet modifies glutamate, gamma-aminobutyric acid and agmatine levels in the hippocampus of rats: A microdialysis study , 2017, Neuroscience Letters.

[10]  C. Zeiss,et al.  β-Hydroxybutyrate Deactivates Neutrophil NLRP3 Inflammasome to Relieve Gout Flares. , 2017, Cell reports.

[11]  M. Cozzolino,et al.  Pathways to mitochondrial dysfunction in ALS pathogenesis. , 2017, Biochemical and biophysical research communications.

[12]  Robert G. Miller,et al.  Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease. , 2017, The Cochrane database of systematic reviews.

[13]  M. Islam Oxidative stress and mitochondrial dysfunction-linked neurodegenerative disorders , 2017, Neurological research.

[14]  E. Weeber,et al.  Ketone ester supplementation attenuates seizure activity, and improves behavior and hippocampal synaptic plasticity in an Angelman syndrome mouse model , 2016, Neurobiology of Disease.

[15]  A. Kavazis,et al.  A Ketogenic Diet in Rodents Elicits Improved Mitochondrial Adaptations in Response to Resistance Exercise Training Compared to an Isocaloric Western Diet , 2016, Front. Physiol..

[16]  N. Lundbom,et al.  Modified Atkins diet induces subacute selective ragged‐red‐fiber lysis in mitochondrial myopathy patients , 2016, EMBO molecular medicine.

[17]  D. Hovda,et al.  Ketogenic diet decreases oxidative stress and improves mitochondrial respiratory complex activity , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[18]  C. Kang,et al.  Exercise-induced hormesis and skeletal muscle health. , 2016, Free radical biology & medicine.

[19]  K. Borges,et al.  Triheptanoin Protects Motor Neurons and Delays the Onset of Motor Symptoms in a Mouse Model of Amyotrophic Lateral Sclerosis , 2016, PloS one.

[20]  P. Corcia,et al.  Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection , 2016, Expert opinion on pharmacotherapy.

[21]  M. Baudry,et al.  Potential therapeutic approaches for Angelman syndrome , 2016, Expert opinion on therapeutic targets.

[22]  B. Bistrian,et al.  Eucaloric Ketogenic Diet Reduces Hypoglycemia and Inflammation in Mice with Endotoxemia , 2016, Lipids.

[23]  J. Mahmoudi,et al.  The efficacy of the ketogenic diet on motor functions in Parkinson’s disease: A rat model , 2016, Iranian journal of neurology.

[24]  A. Branco,et al.  Ketogenic diets: from cancer to mitochondrial diseases and beyond , 2016, European journal of clinical investigation.

[25]  B. J. Turner,et al.  AMPK Signalling and Defective Energy Metabolism in Amyotrophic Lateral Sclerosis , 2016, Neurochemical Research.

[26]  H. Arai,et al.  Clinical Interventions in Aging Dovepress , 2022 .

[27]  A. Köfalvi,et al.  Ketone bodies effectively compete with glucose for neuronal acetyl‐CoA generation in rat hippocampal slices , 2015, NMR in biomedicine.

[28]  A. Tagliabue,et al.  Short-term effects of ketogenic diet on anthropometric parameters, body fat distribution, and inflammatory cytokine production in GLUT1 deficiency syndrome. , 2015, Nutrition.

[29]  S. Auvin,et al.  Ketogenic diet exhibits anti‐inflammatory properties , 2015, Epilepsia.

[30]  P. A. Crawford,et al.  Ketone body β-hydroxybutyrate blocks the NLRP3 inflammasome-mediated inflammatory disease , 2015, Nature Medicine.

[31]  T. Vanitallie,et al.  A new way to produce hyperketonemia: Use of ketone ester in a case of Alzheimer's disease , 2015, Alzheimer's & Dementia.

[32]  J. Rho,et al.  Ketogenic diets, mitochondria, and neurological diseases , 2014, Journal of Lipid Research.

[33]  Min Jung Park,et al.  Anaplerotic Triheptanoin Diet Enhances Mitochondrial Substrate Use to Remodel the Metabolome and Improve Lifespan, Motor Function, and Sociability in MeCP2-Null Mice , 2014, PloS one.

[34]  R. Veech Ketone ester effects on metabolism and transcription , 2014, Journal of Lipid Research.

[35]  K. Nakken,et al.  Does ketogenic diet improve cognitive function in patients with GLUT1-DS? A 6- to 17-month follow-up study , 2014, Epilepsy & Behavior.

[36]  P. Corcia,et al.  The glutamate hypothesis in ALS: pathophysiology and drug development. , 2014, Current medicinal chemistry.

[37]  T. Vanitallie,et al.  Ketone body therapy: from the ketogenic diet to the oral administration of ketone ester , 2014, Journal of Lipid Research.

[38]  V. Stallings,et al.  Long‐term impact of the ketogenic diet on growth and resting energy expenditure in children with intractable epilepsy , 2014, Developmental medicine and child neurology.

[39]  C. Ari,et al.  Metabolic Therapy with Deanna Protocol Supplementation Delays Disease Progression and Extends Survival in Amyotrophic Lateral Sclerosis (ALS) Mouse Model , 2014, PloS one.

[40]  A. Bianco,et al.  Ketogenic Diet in Neuromuscular and Neurodegenerative Diseases , 2014, BioMed research international.

[41]  E. Génin,et al.  A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. , 2014, Brain : a journal of neurology.

[42]  M. Tarnopolsky,et al.  Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes (MELAS) may respond to adjunctive ketogenic diet. , 2014, Pediatric neurology.

[43]  K. Behar,et al.  The Contribution of Ketone Bodies to Basal and Activity-Dependent Neuronal Oxidation in Vivo , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[44]  Ronghao Yu,et al.  [A clinical trial of ketogenic diet in patients with acute spinal cord injury: safety and feasibility]. , 2014, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[45]  H. Fuchs,et al.  Mitochondrial Dysfunction and Decrease in Body Weight of a Transgenic Knock-in Mouse Model for TDP-43* , 2014, The Journal of Biological Chemistry.

[46]  E. Verdin,et al.  Ketone bodies as signaling metabolites , 2014, Trends in Endocrinology & Metabolism.

[47]  D. Morales‐Alamo,et al.  Free radicals and sprint exercise in humans , 2014, Free radical research.

[48]  Brett J. Hilton,et al.  Ketogenic Diet Improves Forelimb Motor Function after Spinal Cord Injury in Rodents , 2013, PloS one.

[49]  P. Caroni,et al.  Neuroprotection through Excitability and mTOR Required in ALS Motoneurons to Delay Disease and Extend Survival , 2013, Neuron.

[50]  Qiong Wu,et al.  3-Hydroxybutyrate methyl ester as a potential drug against Alzheimer's disease via mitochondria protection mechanism. , 2013, Biomaterials.

[51]  Leif Benner,et al.  Ketogenic Diet Improves Motor Performance but Not Cognition in Two Mouse Models of Alzheimer’s Pathology , 2013, PloS one.

[52]  J. LaManna,et al.  Ketosis Proportionately Spares Glucose Utilization in Brain , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[53]  Carl E Stafstrom,et al.  How Does the Ketogenic Diet Work? Four Potential Mechanisms , 2013, Journal of child neurology.

[54]  M. Murphy,et al.  A ketogenic diet improves motor performance but does not affect β-amyloid levels in a mouse model of Alzheimer's Disease , 2013, Brain Research.

[55]  S. Petri,et al.  Prevalence and prognostic impact of comorbidities in amyotrophic lateral sclerosis , 2013, European journal of neurology.

[56]  E. Wirrell,et al.  Ketogenic Diet , 2013, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[57]  Gary Yellen,et al.  The ketogenic diet: metabolic influences on brain excitability and epilepsy , 2013, Trends in Neurosciences.

[58]  U. Baxa,et al.  A ketogenic diet increases brown adipose tissue mitochondrial proteins and UCP1 levels in mice , 2013, IUBMB life.

[59]  G. Pasinetti,et al.  Caprylic Triglyceride as a Novel Therapeutic Approach to Effectively Improve the Performance and Attenuate the Symptoms Due to the Motor Neuron Loss in ALS Disease , 2012, PloS one.

[60]  M. McKenna Substrate Competition Studies Demonstrate Oxidative Metabolism of Glucose, Glutamate, Glutamine, Lactate and 3-Hydroxybutyrate in Cortical Astrocytes from Rat Brain , 2012, Neurochemical Research.

[61]  E. Thiele,et al.  Low glycemic index treatment for seizures in Angelman syndrome , 2012, Epilepsia.

[62]  T. Vanitallie,et al.  Kinetics, safety and tolerability of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate in healthy adult subjects. , 2012, Regulatory toxicology and pharmacology : RTP.

[63]  S. Bröer,et al.  Metabolism, Compartmentation, Transport and Production of Acetate in the Cortical Brain Tissue Slice , 2012, Neurochemical Research.

[64]  K. Clarke,et al.  Oral 28-day and developmental toxicity studies of (R)-3-hydroxybutyl (R)-3-hydroxybutyrate. , 2012, Regulatory toxicology and pharmacology : RTP.

[65]  G. Dienel,et al.  Brain Lactate Metabolism: The Discoveries and the Controversies , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[66]  U. Baxa,et al.  Mitochondrial biogenesis and increased uncoupling protein 1 in brown adipose tissue of mice fed a ketone ester diet , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[67]  Ketogenic diets in the treatment of epilepsy , 2012, Drug and Therapeutics Bulletin.

[68]  Jong M. Rho,et al.  The Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders , 2012, Front. Pharmacol..

[69]  Pierre J Magistretti,et al.  Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation. , 2011, Cell metabolism.

[70]  A. D’Aniello,et al.  Low glycemic index diet in children and young adults with refractory epilepsy: First Italian experience , 2011, Seizure.

[71]  U. Sonnewald,et al.  β-Hydroxybutyrate is the preferred substrate for GABA and glutamate synthesis while glucose is indispensable during depolarization in cultured GABAergic neurons , 2011, Neurochemistry International.

[72]  D. Wallace,et al.  Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome , 2011, Neuroscience Letters.

[73]  R. Nicoll,et al.  Metabolic Control of Vesicular Glutamate Transport and Release , 2010, Neuron.

[74]  M. Spilioti,et al.  Ketogenic diet in a patient with Angelman syndrome , 2010, Pediatrics international : official journal of the Japan Pediatric Society.

[75]  P. Stafford,et al.  The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma , 2010, Nutrition & metabolism.

[76]  L. Petrucelli,et al.  Wild-Type Human TDP-43 Expression Causes TDP-43 Phosphorylation, Mitochondrial Aggregation, Motor Deficits, and Early Mortality in Transgenic Mice , 2010, The Journal of Neuroscience.

[77]  E. Bergbower,et al.  Seizure tests distinguish intermittent fasting from the ketogenic diet , 2010, Epilepsia.

[78]  M. Orešič,et al.  Ketogenic diet slows down mitochondrial myopathy progression in mice. , 2010, Human molecular genetics.

[79]  J. Rho,et al.  Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors , 2010, Journal of neurochemistry.

[80]  Bao-hua Cheng,et al.  Neuroprotective and Anti-inflammatory Activities of Ketogenic Diet on MPTP-induced Neurotoxicity , 2010, Journal of Molecular Neuroscience.

[81]  Shuwei Liu,et al.  Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease , 2009, Brain Research.

[82]  L. Costantini,et al.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial , 2009, Nutrition & metabolism.

[83]  E. Kossoff,et al.  Empiric Use of Potassium Citrate Reduces Kidney-Stone Incidence With the Ketogenic Diet , 2009, Pediatrics.

[84]  S. Heinrichs,et al.  Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets , 2009, Epilepsy & Behavior.

[85]  E. Ishii,et al.  β-hydroxybutyrate alters GABA-transaminase activity in cultured astrocytes , 2009, Brain Research.

[86]  A. Hartman,et al.  The ketogenic diet: Uses in epilepsy and other neurologic illnesses , 2008, Current treatment options in neurology.

[87]  L. Mascitelli,et al.  DYSLIPIDEMIA IS A PROTECTIVE FACTOR IN AMYOTROPHIC LATERAL SCLEROSIS , 2008, Neurology.

[88]  M. Febbraio,et al.  Effect of high-frequency resistance exercise on adaptive responses in skeletal muscle. , 2007, Medicine and science in sports and exercise.

[89]  I. Nissim,et al.  The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. , 2007, Annual review of nutrition.

[90]  J. Rho,et al.  Ketone bodies are protective against oxidative stress in neocortical neurons , 2007, Journal of neurochemistry.

[91]  M. J. Marques-Dias,et al.  Ketogenic diet for the treatment of refractory epilepsy: a 10 year experience in children. , 2007, Arquivos de neuro-psiquiatria.

[92]  J. Rho,et al.  Ketones inhibit mitochondrial production of reactive oxygen species production following glutamate excitotoxicity by increasing NADH oxidation , 2007, Neuroscience.

[93]  H. Heinze,et al.  Metabolic progression markers of neurodegeneration in the transgenic G93A‐SOD1 mouse model of amyotrophic lateral sclerosis , 2007, The European journal of neuroscience.

[94]  V. Stallings,et al.  Vitamin D Status in Children with Intractable Epilepsy, and Impact of the Ketogenic Diet , 2007, Epilepsia.

[95]  J. Rho,et al.  Anticonvulsant Mechanisms of the Ketogenic Diet , 2007, Epilepsia.

[96]  Michael A. Rogawski,et al.  Neuroprotective and disease-modifying effects of the ketogenic diet , 2006, Behavioural Pharmacology.

[97]  Y. Smith,et al.  Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet , 2006, Annals of neurology.

[98]  D. Keene A systematic review of the use of the ketogenic diet in childhood epilepsy. , 2006, Pediatric neurology.

[99]  N. Siva Can ketogenic diet slow progression of ALS? , 2006, The Lancet Neurology.

[100]  Stephanie C. Licata,et al.  Bioenergetic abnormalities in discrete cerebral motor pathways presage spinal cord pathology in the G93A SOD1 mouse model of ALS , 2006, Neurobiology of Disease.

[101]  M. Mattson,et al.  Interferon‐γ is up‐regulated in the hippocampus in response to intermittent fasting and protects hippocampal neurons against excitotoxicity , 2006, Journal of neuroscience research.

[102]  D. MacGrogan,et al.  A ketogenic diet as a potential novel therapeutic intervention in amyotrophic lateral sclerosis , 2006, BMC Neuroscience.

[103]  E. Thiele,et al.  Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet , 2006, Movement disorders : official journal of the Movement Disorder Society.

[104]  A. Cnaan,et al.  Fasting versus Gradual Initiation of the Ketogenic Diet: A Prospective, Randomized Clinical Trial of Efficacy , 2005, Epilepsia.

[105]  L. Stamp,et al.  Diet and rheumatoid arthritis: a review of the literature. , 2005, Seminars in arthritis and rheumatism.

[106]  F. Rise,et al.  Brain metabolism of exogenous pyruvate , 2005, Journal of neurochemistry.

[107]  E. Kossoff,et al.  The Ketogenic Diet , 2005, The neurologist.

[108]  S. B. Heymsfield,et al.  Treatment of Parkinson disease with diet-induced hyperketonemia: A feasibility study , 2005, Neurology.

[109]  C. Bondy,et al.  Caloric restriction augments brain glutamic acid decarboxylase‐65 and ‐67 expression , 2004, Journal of neuroscience research.

[110]  J. Aronson,et al.  What is a clinical trial? , 2004, British journal of clinical pharmacology.

[111]  J. Rho,et al.  The ketogenic diet increases mitochondrial uncoupling protein levels and activity , 2004, Annals of neurology.

[112]  T. Cullingford The ketogenic diet; fatty acids, fatty acid-activated receptors and neurological disorders. , 2004, Prostaglandins, leukotrienes, and essential fatty acids.

[113]  M. Reger,et al.  Effects of β-hydroxybutyrate on cognition in memory-impaired adults , 2004, Neurobiology of Aging.

[114]  E. Kossoff,et al.  Efficacy of the Atkins diet as therapy for intractable epilepsy , 2003, Neurology.

[115]  C. Gottfried,et al.  Ketogenic Diet Increases Glutathione Peroxidase Activity in Rat Hippocampus , 2003, Neurochemical Research.

[116]  M. Vila,et al.  D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease. , 2003, The Journal of clinical investigation.

[117]  J. Rychik,et al.  Selenium Deficiency Associated with Cardiomyopathy: A Complication of the Ketogenic Diet , 2003, Epilepsia.

[118]  Christina Bergqvist,et al.  In vivo measurement of brain metabolites using two‐dimensional double‐quantum MR spectroscopy—exploration of GABA levels in a ketogenic diet , 2003, Magnetic resonance in medicine.

[119]  D. D. Fraser,et al.  Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet , 2003, Neurology.

[120]  G. Liebhaber,et al.  Ketogenic Diet in Rett Syndrome , 2003, Journal of child neurology.

[121]  M. Beal,et al.  Mutated Human SOD1 Causes Dysfunction of Oxidative Phosphorylation in Mitochondria of Transgenic Mice* , 2002, The Journal of Biological Chemistry.

[122]  Robert W. Taylor,et al.  Mitochondrial dysfunction in a cell culture model of familial amyotrophic lateral sclerosis. , 2002, Brain : a journal of neurology.

[123]  Zuoshang Xu,et al.  A quantitative histochemical assay for activities of mitochondrial electron transport chain complexes in mouse spinal cord sections , 2002, Journal of Neuroscience Methods.

[124]  E. Schon,et al.  Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients , 2002, Journal of neurochemistry.

[125]  M. Guzmán,et al.  Is there an astrocyte–neuron ketone body shuttle? , 2001, Trends in Endocrinology & Metabolism.

[126]  Britton Chance,et al.  Ketone Bodies, Potential Therapeutic Uses , 2001, IUBMB life.

[127]  C. Elger,et al.  Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. , 2000, Brain : a journal of neurology.

[128]  K. Clarke,et al.  D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[129]  Naomi Aronson,et al.  Ketogenic Diet for the Treatment of Refractory Epilepsy in Children: A Systematic Review of Efficacy , 2000, Pediatrics.

[130]  M. Mattson,et al.  2‐deoxy‐d‐glucose protects hippocampal neurons against excitotoxic and oxidative injury: Evidence for the involvement of stress proteins , 1999, Journal of neuroscience research.

[131]  Steven B Heymsfield,et al.  Organ-tissue mass measurement allows modeling of REE and metabolically active tissue mass. , 1998, American journal of physiology. Endocrinology and metabolism.

[132]  H. Brunengraber Potential of ketone body esters for parenteral and oral nutrition. , 1997, Nutrition.

[133]  M. Erecińska,et al.  Regulation of GABA Level in Rat Brain Synaptosomes: Fluxes Through Enzymes of the GABA Shunt and Effects of Glutamate, Calcium, and Ketone Bodies , 1996, Journal of neurochemistry.

[134]  M. Bixel,et al.  Generation of Ketone Bodies from Leucine by Cultured Astroglial Cells , 1995, Journal of neurochemistry.

[135]  Basil Künnecke,et al.  Cerebral metabolism of [1,2‐13C2]glucose and [U‐13C4]3‐hydroxybutyrate in rat brain as detected by 13C NMR spectroscopy , 1993, NMR in biomedicine.

[136]  N. Auestad,et al.  Fatty Acid Oxidation and Ketogenesis by Astrocytes in Primary Culture , 1991, Journal of neurochemistry.

[137]  O. Førre,et al.  [Diet and rheumatoid arthritis]. , 1989, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[138]  P. Huttenlocher Ketonemia and Seizures: Metabolic and Anticonvulsant Effects of Two Ketogenic Diets in Childhood Epilepsy , 1976, Pediatric Research.

[139]  H. Mcilwain Brain Metabolism , 1973, Nature.

[140]  C. Rae,et al.  β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms , 2016, Neurochemical Research.

[141]  J. LaManna,et al.  Ketones suppress brain glucose consumption. , 2009, Advances in Experimental Medicine and Biology.

[142]  C. Robertson,et al.  Cerebral metabolism. , 1994, Neurosurgery clinics of North America.

[143]  D. Trauner,et al.  Therapeutic effects of a ketogenic diet in Rett syndrome. , 1986, American journal of medical genetics. Supplement.